TNFRSF18 and neoplasm: In tumor-infiltrating lymphocytes and peripheral blood of HCCs, Zhang et al. [32] revealed that the prevalence of Tregs expressing high levels of HLA-DR, GITR, and CD103 increased during the progressive stages.